Showing results (271-280 of 293) with videos related to

Sort By:
Pageof 30
International Journal of Radiation Oncology, Biology, Physics|December 26, 2025
Enhancing Radiotherapy Quality Assurance in Lymphoma: A Rigorous Real-Time Central Review Process in AHOD2131Andrea C Lo, Sarah A Milgrom, Raymond Mailhot Vega, et al.
Pediatrics|August 2, 2019
Local Anesthesia With General Anesthesia for Pediatric Bone Marrow ProceduresSara Zarnegar-Lumley, Katharine R Lange, Melissa D Mathias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2015
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate CancerNeeta Pandit-Taskar, Joseph A O'Donoghue, Jeremy C Durack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2021
High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and ParagangliomaAbhishek Jha, David Taïeb, Jorge A Carrasquillo, et al.
Pediatric Blood & Cancer|July 5, 2024
Ovarian function in female survivors of high-risk neuroblastomaLauren Jimenez-Kurlander, Amelia DeRosa, Caroline E Kostrzewa, et al.
Cancer Chemotherapy and Pharmacology|January 26, 2017
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)Ghassan K Abou-Alfa, Chia-Jui Yen, Chih-Hung Hsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid TumorsBirgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.
Plos One|June 6, 2017
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumorsOren J Becher, Nathan E Millard, Shakeel Modak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2023
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric CancerSteven B Maron, Walid Chatila, Henry Walch, et al.
Pageof 30